Urgent need for Alzheimer's drug development identified: 99.6 percent of drug attempts fail

Researchers have conducted the first-ever analysis of clinical trials for Alzheimer's disease, revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments.

Read the whole article on Science Daily

More from Science Daily